Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS) SHH

8.85

+0.07(+0.80%)

Updated at September 30 11:29AM

Currency In CNY

Valuation

Market Cap6.34B
Enterprise Value7.09B
P/E Ratio-24.04
PEG Ratio0.28
Price/Sales Ratio2.87
Price/Book Ratio5.11
Enterprise/Revenue3.54
Enterprise/EBITDA-39.96

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.12
Operating Margin-0.12

Management Effectiveness

Return On Assets-0.05
Return On Equity-0.18

Income Statement

Revenue1.41B
Revenue/Share3.04
Gross Profit676.44M
EBITDA-159.6M
Net Income-274.46M
Diluted EPS-0.69

Balance Sheet

Total Cash168.72M
Total Cash/Share0.42
Total Debt988.79M
Total Debt/Equity1.41
Current Ratio0.89
Book Value Per Share1.84

Price History

52-Week Change-36.47
52-Week High25.16
52-Week Low8.18
Moving Average 50 Days9.21
Moving Average 200 Days12.68

Statistics

Average Volume5.63M
Shares Outstanding400.11M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.6
Last Split FactorN/A
Last Split DateN/A